MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Anxiety"

  • 2019 International Congress

    Study of prevalence of Axis-1 DSM-4 psychiatric disorders in patients with parkinsonism in a rural movement disorder clinic in Western India

    D. Desai, S. Singh, S. Desai (Anand, India)

    Objective: To assess the prevalence of Axis-1 DSM-4 [The Diagnostic and Statistical Manual of Mental disorders] psychiatric disorders in patients with Parkinson’s disease [PD], atypical…
  • 2019 International Congress

    Prevalence and factors related to orthostatic hypotension and orthostatic intolerance in recently-diagnosed, drug-naïve Parkinson’s disease patients

    S. Perez-Lloret, C. Quarracino, F. Capani, M. Otero-Losada (Buenos Aires, Argentina)

    Objective: To explore the prevalence and factors related to orthostatic hypotension (OH) and orthostatic intolerance (OI) in recently diagnosed drug-naïve PD patients from the Parkinson’s…
  • 2019 International Congress

    Frequency of neuropsychiatric symptoms in non-demented early and late-onset Parkinson’s disease patients

    A. Seubert-Ravelo, MG. Yáñez-Téllez, G. Neri-Nani, X. Ortiz-Jiménez, C. Guerra-Galicia (Estado de México, Mexico)

    Objective: To compare the frequency of neuropsychiatric symptoms (NPS) (depression, anxiety, psychotic, irritability, aggression, euphoria, apathy, behavioral disinhibition, repetitive motor behavior (RMB) and eating disorder)…
  • 2019 International Congress

    Pursuit of Psychosocial Intervention for Depression and Anxiety in Japanese Parkinson’s Disease patients: Two Studies of Cognitive Behavioral Therapy

    I. Shinmei, N. Nishikawa (Tokyo, Japan)

    Objective: From 2013 to the present, we have explored the feasibility of cognitive behavioral therapy (CBT) for Japanese Parkinson’s disease (PD) patients with depression and…
  • 2019 International Congress

    Restless leg syndrome in Neuro-Behcet’s and Behcet’s disease

    M. Kuzu Kumcu, S. Erdoğan, M. Sorgun, C. Yücesan (Ankara, Turkey)

    Objective: The goal of this study is the comparison of the restless leg syndrome frequency in the BD and NBD patients and also to investigate…
  • 2019 International Congress

    Anxiety and dopaminergic stimulation in patients with Parkinson´s disease.

    A. Camacho Nieto, AR. Franco Salinas, L. Ruiz-Escribano Menchen, MJ. Gallardo Alcañiz, JP. Cabello Rosa, J. Vaamonde Gamo (Ciudad Real, Spain)

    Objective: To report two patients with Parkinson disease and describe the response of this non motor symptom to dopaminergic therapy. Background: Anxiety is frequent comorbidity…
  • 2019 International Congress

    Predictors of Health-Related Quality of Life in Patients with Cervical Dystonia

    SA. Reijneveld, Z. Gdovinova, MAJ. Tijssen, JP. van Dijk, T. Hoekstra, M. Turcanova Koprusakova, M. Smit, M. Skorvanek, V. Han (Martin, Slovakia)

    Objective: The aim of our study was to assess the prevalence of non-motor symptoms (NMS) and to explore their association with health-related quality of life…
  • 2019 International Congress

    Alexander Technique Group Classes Are a Feasible and Promising Intervention for Care Partners of People living with Parkinson’s disease

    M. Gross, R. Ravichandra, B. Mello, R. Cohen (Candler, NC, USA)

    Objective: To test an adapted Alexander technique (AT) group course to improve quality of life for care partners of people living with Parkinson’s disease (PLwPD).…
  • 2019 International Congress

    Repetitive transcranial magnetic stimulation can improve anxiety in Parkinson’s disease: a randomized, double-blind and controlled trial

    A. Makkos-Weisz, N. Kovács, P. Endre, M. Kovács, D. Pintér (Pécs, Hungary)

    Objective: High frequrncy (HF) repetitive transcranial magnetic stimulation (rTMS) improve anxiety in Parkinson’s Disease (PD). Background: The high frequency repetitive transcranial magnetic stimulation above the…
  • 2019 International Congress

    Prefrontal cortex high beta power correlates with the severity of anxiety and depression in Parkinson’s disease patients

    C. de Hemptinne, W. Chen, C. Racine, A. Seritan, J. Mergenthaler, S. Rajagopalan, J. Ostrem, P. Starr (San Francisco, CA, USA)

    Objective: To investigate the neural correlates of anxiety and depression in PD patients and to develop a novel neurostimulation therapy for these non-motor symptoms. Background:…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley